U.S. flag

An official website of the United States government

NM_000318.3(PEX2):c.163G>A (p.Glu55Lys) AND Peroxisome biogenesis disorder

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jul 27, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003323360.2

Allele description [Variation Report for NM_000318.3(PEX2):c.163G>A (p.Glu55Lys)]

NM_000318.3(PEX2):c.163G>A (p.Glu55Lys)

Gene:
PEX2:peroxisomal biogenesis factor 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
8q21.13
Genomic location:
Preferred name:
NM_000318.3(PEX2):c.163G>A (p.Glu55Lys)
HGVS:
  • NC_000008.11:g.76984016C>T
  • NG_008371.1:g.21273G>A
  • NM_000318.2:c.163G>A
  • NM_000318.3:c.163G>AMANE SELECT
  • NM_001079867.2:c.163G>A
  • NM_001172086.2:c.163G>A
  • NM_001172087.2:c.163G>A
  • NP_000309.2:p.Glu55Lys
  • NP_001073336.2:p.Glu55Lys
  • NP_001165557.2:p.Glu55Lys
  • NP_001165558.2:p.Glu55Lys
  • NC_000008.10:g.77896252C>T
  • P28328:p.Glu55Lys
Protein change:
E55K; GLU55LYS
Links:
UniProtKB: P28328#VAR_011389; OMIM: 170993.0002; dbSNP: rs61752119
NCBI 1000 Genomes Browser:
rs61752119
Molecular consequence:
  • NM_000318.3:c.163G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001079867.2:c.163G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001172086.2:c.163G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001172087.2:c.163G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Peroxisome biogenesis disorder (PBD, ZSS)
Synonyms:
PEROXISOME BIOGENESIS DISORDER (NEONATAL ADRENOLEUKODYSTROPHY/INFANTILE REFSUM DISEASE); INFANTILE PHYTANIC ACID STORAGE DISEASE; PEROXISOME BIOGENESIS DISORDER (NALD/IRD); See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0019234; MedGen: C1832200; OMIM: PS214100

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004028599Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely pathogenic
(Jul 27, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Temperature-sensitive phenotypes of peroxisome-assembly processes represent the milder forms of human peroxisome-biogenesis disorders.

Imamura A, Tsukamoto T, Shimozawa N, Suzuki Y, Zhang Z, Imanaka T, Fujiki Y, Orii T, Kondo N, Osumi T.

Am J Hum Genet. 1998 Jun;62(6):1539-43. No abstract available.

PubMed [citation]
PMID:
9585609
PMCID:
PMC1377160

Defective PEX gene products correlate with the protein import, biochemical abnormalities, and phenotypic heterogeneity in peroxisome biogenesis disorders.

Shimozawa N, Imamura A, Zhang Z, Suzuki Y, Orii T, Tsukamoto T, Osumi T, Fujiki Y, Wanders RJ, Besley G, Kondo N.

J Med Genet. 1999 Oct;36(10):779-81.

PubMed [citation]
PMID:
10528859
PMCID:
PMC1734244
See all PubMed Citations (3)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004028599.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

Variant summary: PEX2 c.163G>A (p.Glu55Lys) results in a conservative amino acid change to a highly conserved residue (HGMD) located in the Pex, N-terminal (IPR006845) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251214 control chromosomes (gnomAD). c.163G>A has been reported in the literature in an individual affected with Refsum disease who was compound heterozygous with a pathogenic variant (Imamura_1998, Shimozawa_1999). These data suggest the variant may be associated with disease. At least two publications report experimental evidence evaluating an impact on protein function, finding that cells expressing the variant protein showed partially reduced enzymatic activity and recapitulated the catalase-less persoxisomes seen in patient cells (Fujiwara_2000, Shimozawa_1999). The following publications have been ascertained in the context of this evaluation (PMID: 9585609, 10528859, 10960480). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 3, 2023